Molecular Partners Hits Brakes On IPO In Shaky Market
Swiss biotechnology company Molecular Partners AG has become the latest European company to postpone a planned initial public offering amid widespread market tumult driven by worry surrounding plummeting oil prices and...To view the full article, register now.
Already a subscriber? Click here to view full article